Noticing Weakness In Several Generic Names Thurs.: Impax Labs Down 8%, Lannett Shares Down 4.4%; Not Seeing Any News To Justify Price Action; However, Lannett Shares Were Up 9% On Wed. Amid FDA Approval For Oxycodone, Acetaminophen Tablets